NRXP
NASDAQ · Pharmaceuticals
Nrx Pharmaceuticals Inc
$3.15
+0.03 (+0.96%)
Open$3.16
Previous Close$3.12
Day High$3.30
Day Low$2.95
52W High$5.06
52W Low$1.62
Volume—
Avg Volume978.4K
Market Cap152.46M
P/E Ratio—
EPS$-1.28
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+575.6% upside
Current
$3.15
$3.15
Target
$21.28
$21.28
$14.65
$21.28 avg
$27.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.77M | 21.55M | 19.28M |
| Net Income | -64,731,773 | 2.70M | 1.92M |
| Profit Margin | -2,336.5% | 12.5% | 10.0% |
| EBITDA | -50,555,060 | 4.73M | 4.55M |
| Free Cash Flow | — | 2.93M | 1.59M |
| Rev Growth | — | +2.0% | +3.7% |
| Debt/Equity | 1.42 | 0.67 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |